We assayed the expression of TFF1, a marker expressed at higher levels in primary BC patients with relapse to the bone [37] and angiopoietin-1 (angpt1), which is involved in the angiogenic response of the osteomimicry-related markers [38,39]. The gene discussed is TFF1; the disease is breast cancer.